Back to search

Article

Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity

2021-05-20

Abstract excerpt

<h4>ABSTRACT</h4> Global deployment of vaccines that can provide protection across several age groups is still urgently needed to end the COVID-19 pandemic especially for low- and middle-income countries. While vaccines against SARS-CoV-2 based on mRNA and adenoviral-vector technologies have been rapidly developed, additional practical and scalable SARS-CoV-2 vaccines are needed to meet global demand. In this con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
872b1099-51f5-5d13-b5ad-d76f60f2d4ec
DOI
10.1101/2021.05.20.444848
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityDOI 10.1101/2021.05.20.444848
Select a neighboring publication to make it the new centre.